PharmGKB Blog
Friday, February 28, 2014

CPIC abacavir & HLA-B guideline update published

›
CPIC has extensively reviewed the literature and concluded no changes are required to the therapeutic recommendations of the abacavir dosin...
Tuesday, February 18, 2014

The Uncertain Future of Genetic Testing

›
In an opinion piece from authors at the Stanford Center for Law and the Biosciences, the future of genetic testing is discussed.  After a...
Thursday, February 6, 2014

CPIC Publishes Their Guideline Development Process

›
In Current Drug Metabolism , the Clinical Pharmacogenetics Implementation Consortium ( CPIC ) has defined the standardized operating procedu...
Friday, January 24, 2014

CPIC guidelines for CYP2D6 genotypes and codeine therapy: 2014 Update

›
The Clinical Pharmacogenetics Implementation Consortium ( CPIC ) has published updates to the guidelines for the use of genetic test re...

The Genetics/Genomics Competency Center (G2C2) adds a new PGx section

›
The Genetics/Genomics Competency Center ( G2C2 )  is a free, online resource that provides a collection of high quality educational material...
Thursday, January 16, 2014

Pharmacodynamic pathways for drugs that lower uric acid levels

›
Unlike other animals, humans and apes have lost the ability to break down uric acid. High uric acid levels (hyperuricemia) can result in gou...
Friday, December 20, 2013

Mixed Results for Genotype-guided Warfarin Dosing - Update

›
Update: New perspective piece from the New England Journal of Medicine The December 12 issue of the New England Journal of Medicine ...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.